Moderna (MRNA) PT Raised to $43 at Oppenheimer; 'COVID-19 Vaccine Potential Taking Shape'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. FND
9. DASH
10. GILD

Go back to Moderna (MRNA) PT Raised to $43 at Oppenheimer; 'COVID-19 Vaccine Potential Taking Shape'

Moderna Highlights Opportunity of mRNA Vaccines at its First Vaccines Day

April 14, 2020 7:00 AM EDT

Vaccines create significant value for healthcare systems by preventing infectious disease; despite this, the vast majority of viruses do not have commercial vaccines available, representing a large opportunity

Moderna has demonstrated neutralizing immunogenicity against all eight viruses targeted in clinical trials to date using the Companys innovative vaccine platform

First interim analysis of Phase 1 Zika vaccine candidate (mRNA-1893) study shows that 10 µg and 30 µg dose levels seroconverted 94% and 100% of seronegative participants, respectively, and effectively boosted seropositive participants; both dose levels generally well-tolerated

NIH-led... More